DesirePT-141 (Bremelanotide)
Sexual health from the central nervous system.
About
What it is
PT-141 activates MC4R receptors in the brain to increase sexual desire and arousal. Unlike PDE5 inhibitors that work on blood flow alone, PT-141 works on the desire pathway itself. Effective in both men and women.
How it works
PT-141 activates melanocortin-4 receptors (MC4R) in the hypothalamus, the brain region that governs sexual arousal. Unlike PDE5 inhibitors (sildenafil, tadalafil) that work on penile blood flow, PT-141 stimulates the central desire pathway — which is why it's effective in both men and women.
Benefits
Who it's for
What to expect
Dose 1
Effects typically felt within 1-2 hours. Increased desire and arousal.
Ongoing
Used on-demand before sexual activity. No daily commitment required.
Safety & tolerability
PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder in women. Common side effects include mild nausea and flushing, which typically resolve. It's dosed on-demand, not daily. Our care team reviews your health profile.
How we compound
Single-source API
Every peptide is sourced from one vetted pharmaceutical-grade supplier — no blending from multiple sources.
Third-party tested
Independent labs verify purity, potency, sterility, and endotoxin levels before any batch is released.
Care team reviewed
A real person reviews your profile, your protocol, and your progress. Not an algorithm.
Hormonal Health
DesirePT-141 (Bremelanotide)
Every protocol is reviewed by our care team before it ships. Questions? Learn more
$139/mo
